Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 176-182

  Lenz, H J ^a   Leichman, C G ^a   Danenberg, K D ^a   Danenberg, P V ^a   Groshen, S ^a   Cohen, H ^a   Laine, L ^a   Crookes, P ^a   Silberman, H ^a   Baranda, J ^a   Garcia, Y ^a   Li, J ^a   Leichman, L ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; ENZYME ASSAY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 9044250848     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.176     Document Type: Article

References (27)

1. Heidelberger C, Chandari NK, Dannenberg P, et al: Fluorinated pyrimidines: A new class of tumor inhibitory compounds. Nature 179:663-666, 1957
2. Santi DV, McHenry CS, Sommer H: Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyruridylate. Biochemistry 13:471-481, 1974
3. Hougton JA, Maroda SJ, Phillips JO, et al: Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res 41:144-149, 1981
4. Jastreboff MM, Kedzierska B, Rode W: Altered thymidylate synthase in 5-fluorodeoxyuridine-resistant cultured hepatoma cells. Biochem Pharmacol 32:2259-2267, 1983
5. Barbour KW, Berger SH, Berger FG: Single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase. Mol Pharmacol 37:515-518, 1990
6. Scanlon, KJ Lu Y, Kashani-Sabet M, et al: Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo. Adv Exp Med Biol 244:127-135, 1988
7. Washtien WL: Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity. Mol Pharmacol 21:723-728, 1982
8. Berger SH, Jenh CH, Johnson LF, et al: Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistam human cells. Mol Pharmacol 28:461-467, 1985
9. Swain SM, Lippman ME, Egan EF, et al: Fluorouracil and high dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7:890-899, 1989
10. Chu E, Drake JC, Koeller DM, et al: Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer. Mol Pharmacol 39:136-143, 1991
11. Peters GJ, Van der Wilt CL, Van Groeningen CJ, et al: Thymidylate synthase inhibition after administration of 5-fluorouracil with or without leucovorin; Implications for treatment with 5-fluorouracil. J Clin Oncol 12:2035-2042, 1995
12. Johnston PG, Fisher ER, Rockette HE, et al: The role of thymidylate synthase expression in the prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12:2640-2647, 1994
13. Spears CP, Shahanian AH, Moran RG, et al: In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and - resistant murine colon adenocarcinomas. Cancer Res 42:450-456, 1982
14. Rustum YM, Madajewicz S, Campbell J, et al: The Current Status of 5-Fluorouracil-Leucovorin Calcium Combination. New York, NY, Wiley, 1984, pp 77-82
15. Eisenstein BI: The polymerase chain reaction: A new method of using molecular genetics for medical diagnosis. N Engl J Med 322:181-183, 1990
16. Horikoshi T, Danenberg KD, Stadibauer THW, et al: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52:108-116, 1992
17. Curt GA, Carney DN, Cowan KH, et al: Unstable methotrexate resistance in human small cell carcinoma associated with double minute chromosomes. N Engl J Med 308:199-202, 1983
18. Johnston PG, Lenz HJ, Leichman CG, et al: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55:1407-1412, 1995
19. Leichman L: Cancer of the Esophagus: The Wayne State University Experience: Perspective of a medical oncologist. Invest New Drugs 7:91-100, 1989
20. Shumate CR, Rich TA, Skibber JM, et al: Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma: A report of surgical morbidity. Cancer 71:3690-3693, 1993
21. Leichman L, Cummings B: Cancer of the anal canal. Curr Prob Cancer 3:119-157, 1990
22. Frei A III, Clark JR, Miller D: The concept of neoadjuvant chemotherapy, in Salmon SE (ed): Adjuvant Therapy of Cancer V. Orlando, FL, Grune & Stratton, 1987, p 67-75
23. Leichman L, Silberman H, Leichman CG, et al: Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: A University of Southern California pilot program. J Clin Oncol 10:1933-1942, 1992
24. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
25. Takeishi K, Kaneda S, Ayusawa D, et al: Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acid Res 13:2035-2045, 1987
26. Ng SY, Gunning P, Eddy R, et al: Evolution of the functional human B-actin gene and its multipseudogene family conservation of non-coding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5:2720-2732, 1985
27. Lenz HJ, Ju JF, Danenberg KD, et al: Effect of p53 activity on the cytotoxicity of 5-fluoro-2′deoxyuridine and its inhibition of thymidylate synthase. Proc Am Assoc Caner Res 36:21, 1995 (abstr 121)